| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3996532 | Practical Radiation Oncology | 2016 | 8 Pages |
Abstract
IMRT is associated with significant lower grade 2Â + GI toxicity versus 3D-CRT for patients undergoing definitive chemoradiation therapy for LAPC. Because IMRT is better tolerated at higher doses and may allow further dose escalation, potentially improving local control for this aggressive disease. Further prospective studies of dose-escalated chemoradiation using IMRT are warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Shreya BA, Lajhem BS, Florence MD, PhD, Joanne F. MPH, Zhigang PhD, Abraham J. MD, Eileen M. MD, Peter J. MD, Karyn A. MD, MS,